Skip to main navigation
Skip to search
Skip to main content
Northern Arizona University Home
Search content at Northern Arizona University
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Uphill both ways: Fatigue and quality of life in valley fever
Ashley L. Garrett
, Yu Hui H. Chang
, Kathleen Ganley
, Janis E. Blair
Physical Therapy and Athletic Training
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Uphill both ways: Fatigue and quality of life in valley fever'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Quality of Life
100%
Both-Ways
100%
Valley Fever
100%
Fatigue Severity Scale
100%
Treatment Group
60%
Short Form 36 (SF-36)
60%
Non-treatment
60%
Fatigue Index
40%
Primary Pulmonary Coccidioidomycosis
40%
Antifungal Therapy
40%
Severe Fatigue
40%
Illness
20%
Quality of Life Improvement
20%
Health Status
20%
Mental Health
20%
Multiple Sclerosis
20%
Severely Affected
20%
Respiratory Symptoms
20%
Treatment Decisions
20%
Disease Effects
20%
Early Illness
20%
SF-36 Score
20%
SF-36 Questionnaire
20%
Physical Ability
20%
Physical Functioning
20%
Pulmonary mucormycosis
20%
Systemic Symptoms
20%
Emotional Health
20%
Treating Physicians
20%
Medicine and Dentistry
Quality of Life
100%
Short Form 36
100%
Fatigue Severity Scale
100%
Disease
80%
Group Therapy
60%
Symptom
40%
Population
40%
Antifungal Therapy
40%
Primary Pulmonary Coccidioidomycosis
40%
Observational Study
20%
Health Status
20%
Multiple Sclerosis
20%
Mental Health
20%
Coccidioidomycosis
20%
Antifungal Agent
20%
Emotional Stability
20%
Physical Capacity
20%
Nursing and Health Professions
Quality of Life
100%
Short Form 36
100%
Fatigue Severity Scale
100%
Disease
80%
Group Therapy
60%
Coccidioidomycosis
60%
Population
40%
Symptom
40%
Antifungal Therapy
40%
Health Status
20%
Antifungal Agent
20%
Multiple Sclerosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Coccidioidomycosis
75%
Antifungal Agent
75%
Symptom
50%
Multiple Sclerosis
25%
Observational Study
25%
Health Status
25%
Neuroscience
Antifungal
100%
Multiple Sclerosis
33%
Psychology
Quality of Life
100%